Skip to main content
SleepCited

グリシン酸マグネシウム むずむず脚症候群

F

合計31,304名の参加者を対象とした25件の研究(メタアナリシス3件、RCT 1件を含む)に基づく。25件中15件の研究で肯定的な効果が示されている。

<\/script>\n
`; }, get iframeSnippet() { const domain = 'sleepcited.com'; const params = 'ingredient\u003Dmagnesium\u002Dglycinate\u0026condition\u003Drestless\u002Dleg\u002Dsyndrome'; return ``; }, get activeSnippet() { return this.method === 'script' ? this.scriptSnippet : this.iframeSnippet; }, copySnippet() { navigator.clipboard.writeText(this.activeSnippet).then(() => { this.copied = true; setTimeout(() => { this.copied = false; }, 2000); }); } }" @keydown.escape.window="open = false" @click.outside="open = false">

Embed This Widget

Style



      
      
    

Widget powered by . Free, no account required.

F

結論

Magnesium supplementation may help reduce restless leg syndrome symptoms, especially if you have low magnesium levels, though results vary from person to person.

  • 15 out of 25 studies show positive effects with 31,304 participants across all study types
  • A 2022 RCT showed magnesium plus vitamin B6 alleviated RLS symptoms
  • Low magnesium levels are consistently associated with higher RLS risk
  • Particularly relevant for pregnant women and kidney disease patients with RLS

Key Study Findings

Other
Fresh Genetic Insights Into Micronutrients Influences on Restless Legs Syndrome Risk.
Dose: None vs: None Outcome: Causal association of micronutrients with RLS 効果: Retinol OR 0.46; Mg OR 0.62 None

対象集団: European ancestry (7248 RLS cases, 19802 controls)

Other
Engineered polyphenol-keratin nanocarriers enhance probiotic delivery and ameliorate obese ulcerative colitis.
Dose: None vs: Uncoated EcN and UC model mice Outcome: UC inflammation and probiotic intestinal retention 効果: None None

対象集団: Obese C57 mice with DSS-induced UC

Randomized Controlled Trial
Bacterial cellulose matrix and acellular dermal matrix seeded with fibroblasts grown in platelet-rich plasma supplemented …
Dose: BCM or ADM seeded with PRP-grown fibroblasts vs: Free gingival grafts (FGG) Outcome: Wound healing of mucogingival defects 効果: None None

対象集団: Animal model (mucogingival defects)

Systematic Review
Effects of Dietary Supplementation in Patients with Restless Legs Syndrome: A Systematic Review.
Dose: None vs: None Outcome: Sleep quality 効果: None None

対象集団: None

In Vitro
Biotechnological properties of Bacillus amylolyquefaciens B65 isolated from an artisanal tannery.
Dose: B. amylolyquefaciens B65 lipopeptides vs: None Outcome: Surfactant and antibacterial properties 効果: None None

対象集団: In vitro industrial microbiology study

Other n=10 8 weeks Open-label
Magnesium citrate monotherapy improves restless legs syndrome symptoms and multiple suggested immobilization test scores in …
Dose: 200 mg vs: Placebo Outcome: Quality of life 効果: None P = .006

対象集団: None

Key Statistics

54

研究数

8833

参加者数

Mixed

F

グレード

Referenced Papers

Antioxidants (Basel, Switzerland) 2022 13 件の引用
The lancet. Diabetes … 2020 2 件の引用
Cytotechnology 2016 18 件の引用
MMW Fortschritte der … 2013 3 件の引用
American family physician 2012
Journal of the … 2007 10 件の引用
The British journal … 2006 29 件の引用
Anesthesia and analgesia 2003 1 件の引用
Sleep medicine reviews 1999 31 件の引用
Graefe's archive for … 1997 33 件の引用
The American Journal … 1996 1 件の引用

Dosage & Usage

mg = milligrams · mcg = micrograms (1,000× smaller) · IU = International Units

一般的な使用量

general:
200-400 mg elemental Mg, before bed

上限量: 350 mg/day (supplemental Mg)

研究で検討された用量

用量 期間 効果 N
None -- Mixed --
None -- Positive --
BCM or ADM seeded with PRP-grown fibroblasts -- Positive --
None -- Positive --
B. amylolyquefaciens B65 lipopeptides -- Neutral --
200 mg 8 weeks Mixed 10
5 g -- Positive --
None -- Mixed --

推奨摂取タイミング: 30-60 minutes before bed

Safety & Side Effects

報告されている副作用

  • Loose stools or diarrhea
  • Nausea
  • Abdominal cramping
  • Low blood pressure at high doses

既知の相互作用

  • Antibiotics (tetracyclines, fluoroquinolones) — may reduce absorption
  • Bisphosphonates — magnesium may decrease efficacy
  • Blood pressure medications — additive hypotensive effects

耐容上限摂取量: 350 mg/day (supplemental Mg)

サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。

Frequently Asked Questions

Does グリシン酸マグネシウム help with むずむず脚症候群?
Based on 54 studies with 8,833 participants, there is insufficient evidence at this time that グリシン酸マグネシウム may support むずむず脚症候群 management. Our evidence grade is F (Evidence Against).
How much グリシン酸マグネシウム should I take for むずむず脚症候群?
Studies have used various dosages. A commonly studied range is 200-400 mg elemental Mg, before bed. Always consult your healthcare provider before starting any supplement regimen.
Are there side effects of グリシン酸マグネシウム?
Reported side effects may include Loose stools or diarrhea, Nausea, Abdominal cramping, Low blood pressure at high doses. Most side effects are mild and dose-dependent. Consult your doctor if you experience any adverse reactions.
How strong is the evidence for グリシン酸マグネシウム and むずむず脚症候群?
We rate the evidence as Grade F (Evidence Against). This rating is based on 54 peer-reviewed studies with 8,833 total participants. The overall direction of effect is mixed.

Related Evidence

に関する他の成分: むずむず脚症候群

グリシン酸マグネシウム 他の症状・状態について

FDAに関する免責事項: これらの記述は米国食品医薬品局(FDA)による評価を受けていません。本ウェブサイトの製品および情報は、疾病の診断、治療、治癒、または予防を目的としたものではありません。表示されているエビデンスグレードは、公開された査読済み研究の分析に基づいており、医療上の助言を構成するものではありません。サプリメントの摂取を開始する前に、必ず医療専門家にご相談ください。